Clinical Trial Update: Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Avastin with radiation and temozolomide, followed by Avastin, temozolomide and irinotecan in glioblastoma and gliosarcoma. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Avastin (bevacizumab)
• Camptosar (irinotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2013-01-18